A WORLD-CLASS LINE-UP

Founder of MP Corporate Finance25 yrs and more than 100 M&A transactions in the Packaging IndustryM&A Professional & Packaging Industry Sector Expert

Gurmeet Singh is a senior director, Business Development at West. In her current role, she manages a global team that collaborates with strategic pharmaceutical companies to sell services and solutions to support the development of combination products to bring optimal drug delivery options for patients, caregivers and providers. These include West proprietary product platforms and third party drug delivery solutions, with services that include design and development through clinical readiness to scale-up and manufacturing. Gurmeet is an experienced business leader in pharmaceutical packaging, including drug delivery devices, for injectable drugs with a strong focus in combination product development and commercialization projects working with multiple global pharmaceutical partners. She is passionate about bringing innovative solutions that are designed with the patient in mind, with the intent to improve their lives. Gurmeet is knowledgeable and experienced professional supporting all aspects of device development, cGMP manufacturing as well as global regulatory compliance.

Gemma Budd is Business Development Director for Nanopharm, an Aptar Company, where she is primarily responsible for developing business and collaborative opportunities for Aptar Pharma’s services, solutions and technologies in the orally inhaled and nasal drug product (OINDP) sector. With a university degree in Biomedical Sciences, Gemma has over 10 years of experience in the pharmaceutical industry in both research and commercial positions, from materials science and analytical services, to formulation technology and drug delivery devices, primarily for oral and inhaled dosage forms. 

Dr. Mahler is Founder, CEO and Board Member at ten23 health AG, the human-centric and sustainable pharmaceutical development partner.
He is also adjunct faculty at the Universities of Frankfurt (Germany) and Basel (Switzerland), serves as Scientifc Expert (Ph.Eur.) at EDQM and as Board Member for Bionter & KriyaBio.
Previously, Dr. Mahler has been leading the Drug Product Services Business Unit at Lonza AG, leading Pharmaceutical Development & Supplies Biologics at Roche (Basel), and as Principal Scientist & CMC Team leader Erbitux at Merck KGaA. 
He studied Pharmacy & holds in Ph.D. in Toxicology from the University of Mainz.

Hugo Alexandre Ferreira holds degrees in medicine and in engineering physics and has a PhD in physics on the topic of bionanotechnology. He then worked in the medical device industry prior to returning to academia. Currently, he is an associate professor of biomedical engineering and biophysics at the University of Lisbon, teaching medical devices and digital health, and a PI in the fields of exponential digital technologies applied to health, including AI, XR, 3D printing, BCIs, wearables, and blockchain. Finally, he has co-founded and managed companies in the fields of IVD and imaging diagnostics, digital health, and sports and serves as a consultant and advisor in those fields.

Mr. Hiroki Hasegawa is a researcher of research laboratory. He gained a Diploma in Science in 2013 and a Master Degree of Science in 2015 from Osaka University.Since April 2015 he has been working for Mitsubishi Gas Chemical Company, Inc. and in charge of macromolecular science, especially in composition development of thermosetting resin.Since 2018 he has joined a development team of multilayer plastic vial & syringe for biologics.

Hervé Monchoix is a Strategic Innovation Leader for BD Medical - Pharmaceutical Systems, Strategic Innovation Group, where he is tasked with identifying opportunities and leading projects aimed at developing distinct and novel products, technologies and solutions for the global injectable drug delivery market. Prior to joining BD in 2010, Mr. Monchoix spent more than 15 years in the semiconductor equipment industry, ranging from startups to large companies, in a variety of roles from new product development to commercialization. Mr. Monchoix holds an MS in Electrical Engineering from Arizona State University and a BS in Applied Physics from Institut National Polytechnique de Grenoble (Grenoble, France). He holds seven U.S. and several international patents, and is the author of more than 10 peer-reviewed publications.

Iain is a Commercial Director at Phillips-Medisize, where he is part of a global team developing industry leading solutions and platforms for drug delivery, digital medicine and connected health.He has worked for more than 20 years principally in lifesciences with an increasing focus on the use of devices and digital technologies to support drug deliveryHe has a degree and PhD in physics both from University College London and an MBE in Technology Management from the Open University. He lectures on Bioscience Enterprise at the University of Cambridge and is a regular conference speaker

As the Global Head of Environment and Environmental Sustainability at Sanofi, based in Paris, Jose Francisco leads a diverse team in driving the company's efforts towards environmental sustainability across all aspects of our value chain. This includes initiatives on climate change, water stewardship, eco-design, pharmaceuticals in the environment, waste and circularity, and biodiversity. At Sanofi, we have a strong commitment to not only providing healthcare solutions, but also to minimizing the environmental impact of our products and activities, and building resilience to environmental changes through our 'Planet Care' ambition.

Frederic Vicentini has been working at NXP Semiconductors for the past 9 years and is currently in charge of the business development activities in EMEA for the RFID and NFC product portfolios. Frederic has a strong background of 20+ years in the field of RFID, security, and smart product technologies, and has held several sales and marketing positions in high-tech companies internationally.

Gabriel’s 20 years experience in medtech and pharma product development has stretched from concept feasibility to regulatory approval and launch, including most recently with Connected Health at Novartis for software as a medical device solutions. He has been with Novartis for the last 10 years. Most recently his role has been as Group Head for team on Innovation and User Experience.

Julien Storz is Director of Business Development within Aptar Pharma’s Consumer Healthcare (CHC) division. He holds a bachelor’s degree in Business Administration and has over 19 years of medical industry experience. Julien joined Aptar Pharma and the CHC Global Market Development team in 2019, where he is responsible for supporting business development efforts across numerous application fields in addition to driving CHC sustainability efforts.Join Julien Storz’ Learning Lab presentation to learn more and get introduced to the first in market metal-free recyclable nasal spray pump.

Juergen combines the medical, business and packaging world in his vita. With a bachelor’s degree in International Business Administration and an Executive MBA in Sales & Marketing Management, Jürgen spent the first 20 years of his professional life in different leadership roles in Amcor. Being also an advanced paramedic, he is passionate about the healthcare world and can add first-hand experience as a user to the sterile barrier world. Since 2018, Juergen is with Suedpack Medica and develops with his team the business of the future.

Johanna is Director of User-Centered Design at Merck’s Global Digital Health team where she led the organization’s initiative to create a user centered culture and deploy design thinking methods for all new medical device and digital health projects. Johanna has spent her entire career in product development of medical devices - touching on all aspects from idea generation, screening, concept and product development to commercialization. With a MSc in Mechanical Engineering, she has experienced first-hand the industry’s recognition of user centricity as a driver for end-user value and product development efficiency.

Jim is an experienced medical device and combination product development team leader who has led device development organizations at Jazz Pharmaceuticals, Windtree Therapeutics, and others.  He has successfully brought new and effective products to market throughout the world, developed and implemented new engineering, quality control and manufacturing processes.  At EdgeOne Medical, Jim is responsible for understanding the needs of our clients and offering device development solutions that ensure that the client products are safe and that they get on the market in the most timely way their risk profile allows.  Jim has a BS from the Rochester Institute of Technology and a Master in Science in Engineering Management from Drexel University.

Keith Dodson is Vice President of Global Business Development and leads AST's global sales team. With an engineering background, Keith brings over 26 years total experience in the pharmaceutical and CDMO space having worked for multinational companies including 3M, Thermo Fisher, Eurofins and Catalent. Over his career, Keith has helped his customers around the world to identify, scope, and successfully implement capital equipment and technical services projects addressing critical business needs.

Kristien De Clercq is an experienced mechanical engineer with over nine years’ experience as a consultant in medical device development. She has led and delivered projects in a wide range of medical fields including specialist applications for ophthalmology and vascular conditions. Kristien draws on her background in aerodynamics and biomechanics, to bring creative ideas to her designs. As project leader at Springboard, she has a proven record of delivering technical excellence. She studied for a BSc in Aeronautical Engineering and a MSc in Experimental Aerodynamics at Delft University of Technology, followed by a postgraduate in Zoology at Cambridge University.

Karin von Kienlin is a Senior Partner in L.E.K. Consulting’s Munich office. She is Head of L.E.K. Germany and is an elected member of L.E.K.’s Global Leadership Team.Karin has more than 25 years' experience in growth strategy development and transactions, having worked for a diverse range of industrial clients across Europe, North America and Asia. Karin has a special focus on the paper & packaging industry and has worked for market leading clients across the packaging value chain. Karin is a frequent speaker on panels and in webinars and she regularly publishes packaging related thought leadership insights and reports.

Lionel Jeannin is an Arts & Métiers ParisTech Engineer with a Master's degree in Business Administration from IAE Aix-Marseille Graduate School of Management. He earned certificates in Biochemistry and Biology, respectively, from Harvard University and the Massachusetts Institute of Technology. He has more than 22 years of experience in the Medical Device and Pharmaceutical industry. 
He has worked as a Project and Development Team Manager in the Industrial Engineering, Ophthalmic surgery Medical Devices, Parenteral Nutrition and OTC/Rx Pharmaceutical development domains. He is currently heading the Oral Packaging and Delivery Systems Group in the Global Device and Packaging Development department of Novartis Pharma Technical Research and Development division.

Mark Tunkel is Global Category Director, Services, at Nemera. He was previously a partner at Insight Product Development, which was acquired by Nemera in 2019 and became the Insight Innovation Center. With more than 20 years of global business development experience and a deep understanding of the marketplace challenges and trends impacting the pharma industry, Mr Tunkel has advised many of the world’s leading companies on their product development and innovation strategies, with an emphasis on driving realisation and the most favourable business outcomes.

Mario is an experienced pharmaceutical development professional with over 30 years of CMC contributions to pharmaceutical companies in international environment (Italy, Germany, Switzerland).
He has extensive experience in formulation and process development of Drug Products for clinical supplies, tech transfer and commercial manufacturing, including successful FDA approval of Mavenclad® for multiple sclerosis and Xadago® for Parkinson’s disease. Moreover, he contributed to the invention of a drug delivery system based on mesoporous silica for oral bioavailability enhancement (Parteck® SLC).
Currently he works as freelance CMC consultant, offering high added-value consultancy for Interim Management, CDMO/CMO outsourcing, IND/IMPD writing, EMA/FDA Scientific Advice meetings, due diligences and licensing.
Mario holds a MSc in Pharmacy and a MSc in Pharmaceutical Chemistry and Technology from University of Turin, Italy, and advanced Pharma Management education from London Business School, UK and Columbia Business School, NYC, USA.

Mayur is an accomplished leader with over 18 years of innovative pharma digital health and medical device development experience. He advises pharmaceutical companies on digital health innovation, technology strategy, product development, regulatory and commercialisation aspects. Mayur has led a wide range of development programmes in PA and his past employments. He has a strong track record in leading development of innovative devices and techniques. Mayur has helped PA’s clients to address some of the most stringent technical needs and challenges.

With a Bachelor’s degree in process engineering / mechanical engineering and Master's degree in plastics engineering, Michael is a technology lover and passionate about plastics!  He has more than 25 years’ experience in packaging, and over 15 years in packaging for pharmaceuticals and GMP environment.  Since early 2020 Michael works with SÜDPACK Medica as Head of R&D.  He formerly worked with Etimex Primary Pack as Head of Development.  Michael held various roles with BP in production and development, including application engineering, where he supported machine builders and customers during FAT & SAT, including troubleshooting. Michael was also Head of Sales with responsibility for CPP (Cast Polypropylene).

Dr. Nicolas Brandes is a Director of Product Management, Vial Containment & PFS Solutions at West Pharmaceutical Services.
He gained his PhD in Biology in 2010 at the University of Wuerzburg (Germany) after performing his research studies at the University of Michigan, USA. Dr. Brandes joined West in 2010 and supports the business development, project management and marketing & sales activities related to the Daikyo Crystal Zenith® product portfolio.

Noel Gibbons BSc (Hons) is the Technical Advisor for Medical Device and Pharmaceutical packaging within STERIS AST for the last 21 years. He has significant experience in a wide variety of areas from manufacturing, process validation, package testing, packaging process validation, package integrity testing, quality and international test standards. He has significant practical experience in medical device packaging at all levels, including evaluation of proposed packaging and current packaging designs and related validation documentation. 
Noel has presented nationally and internationally on Medical Device and Pharmaceutical package testing particularly on the requirements of the ISO11607 and associated test standards. He is a featured speaker at international conferences and seminars on medical and pharmaceutical packaging aspects.

Wenzel studied biology, did his PhD in physics at the Max-Planck-Institute for Neurochemistry in Munich.
As head of laboratory in a Swiss biotech-company, he worked on Keratinocytes.
In charge of project management and as head of production for presterilzed syringes, he designed the manufacturing area and operated the production start-up phase.
He took role as Chief-Innovation-Officer at a pharmaceutical equipment supplier. Two years in USA, he developed the market for cell- and gene therapy equipment.
In 2018, he returned to the same primary packaging manufacturer, left 13 years ago in a new global senior role for business development.

Started at Südpack Medica in September 2021.  With a dual Bachelor’s degree in Industrial Design and Mechanical Engineering, Pieter brings over 16 years of experience in healthcare packaging with expertise in rigid barrier packaging.  Focused on including patient safety till the point of care and improving patient outcomes.Formerly worked at Nelipak Healthcare Packaging with multiple international leadership roles in packaging design, development, and innovation management. Active member in Kilmer innovations in Packaging Sustainability committee, education committee, and the Sterile Barrier Association.

Roberto Valenti is Head of Materials Development in Bormioli Pharma. After a first experience as technical for quality control of the raw materials, he has been in charge since January 1999 of the R&D activities aimed at the use and validation of innovative materials, such as sustainable plastics (recycled, bio-based) or barrier materials. Roberto Valenti is constantly updated on the latest developments through a consolidated network of partners and suppliers, supporting clients on their materials innovation projects.

Richard holds a bachelor’s engineering degree with honours in product design for manufacture. Richard started his career as an R&D engineer in 1995 designing inhalation drug delivery devices. He then went on to design combination/medicinal products at Bespak and later transitioned to Covidien (Medtronic) where he held roles in international upstream marketing and business development. He then moved on to various roles at Owen Mumford, Bespak and Novo Nordisk Engineering (NNE) in Denmark, before re-joining Owen Mumford in 2016. Richard is now dedicated to managing new injectable platform devices for Pharma and Biotech companies that meet market and user needs.

Sylvia Kaiser-Kershaw is a Senior Global Marketing Manager in the Connectivity & Security business line at NXP Semiconductors. As part of her role, she helps develop smart solutions for applications in pharmaceuticals and medical devices, e.g., for anti-counterfeit protection and patient adherence applications. Ms Kaiser-Kershaw has over 20 years of experience in strategic brand, segment and product marketing, working across a variety of industries, including personal care, healthcare and insurances. She is based in Austria.

Sona Kovackova holds a PhD degree in Organic Chemistry from the University of Chemistry and Technology, Prague, Czech Republic.She started her career as a Scientist at the Rega Institute for Medical Research KU Leuven, Belgium and later worked in Quality Control of medicines at the Belgian Institute of Public Health.In 2017, Sona took the position of Study Director at Nelson LabsEurope. She currently specializes in Extractables & Leachables studies witha main focus on injectable applications.

Scott Ariagno is Vice President of Engineering and Development Services at EdgeOne Medical and has over 25 years in medical device and combination product design, development and manufacturing.  His expertise includes development and global launch of of various single-use, disposable medical devices, infusion systems and combination products, strategic/technical development of device platforms and IP development. Throughout his career he has held management roles in engineering including heading device development and external manufacturing at Shire (now Takeda).  Scott is a named inventor on over 20 patents and applications.
Scott has Bachelor of Science in Mechanical Engineering from Bradley University and a Master in Engineering Management from Northwestern University.

In his role of Expert Advisor, Stefan leads Ethylene Oxide (EO) sterilization projects in a number of facilities in EMEAA. He also supports the facilities as a technical expert. An experienced trainer, Stefan gives training on EO sterilization to customers and notified bodies. He has also co-authored several peer-reviewed publications in the area of plant biology and a peer-reviewed study on the reduction of PCR-amplifiable DNA by EO treatment of forensic consumables. Education: PhD in Biology and Diploma Degree in Biology, both from Philipps University of Marburg (Germany). Expertise: Ethylene Oxide Sterilization Validation, Product Adoption, Single Lot Release Processing, Validation of Reduction of DNA Contamination on Products for Forensic Use

Dr Sukhada Chaturvedi represents Körber Pharma as an International Account Manager since past almost 2 years. After finishing her master’s degree in microbiology from India, she earned her Doctoral degree in Neuroscience from Hannover Medical School in Germany and worked as a post-doctoral scientist in academia before elaborating roots in pharmaceutical industry. Since past 11 years she has contributed to multiple positions in the areas of clinical research and commercially in Account Management, Sales and Business Development and in the pharma Industry. Her position allows and motivates her to excel in Pharma Consulting against the pain-points in pharma manufacturing, as well as opinionating and networking with experts from the C-level to the operating level in the pharma industry.

I’ve been in the pharmaceutical industry for almost 9 years developing medical devices end to end, primarily in the combination product space. I’ve worked in all phases of development and excel at strategizing organizational development, platforms, and pipelines. Understanding stakeholder needs, the true context of use, and presenting unique solutions are some of my strong suits. With my broad range of product and patient experience, I bring a unique perspective.

Tom leads engineering and scientific teams developing new injection devices, pumps and inhalers. He has been the named inventor on dozens of patents throughout his 20 years’ experience in industry.He is a regular speaker at various international conferences on innovation and medical device development, and mentors Engineering and MBA students at the Cambridge University Engineering Department and the Judge Business School.He read Engineering at Cambridge University before becoming the Choate Fellow in Human Physiology and Pathology at Harvard University.

Tom Van Ginneken studied chemical engineering in Antwerp and added a MBA from the university of Sankt Gallen to his resume. After working in the chemical and pharmaceutical sector in Belgium for 3 years he joined SCHOTT in 2008.After different positions in the pharmaceutical product development department he became part of the product management team with focus on the SCHOTT TOPPAC® brand. In this role he works on the strategic orientation and innovation pipeline of the product group.